IDS, a leading producer of diagnostic testing kits, announces the completion of the acquisition of 99.93% of the ordinary share capital of Biocode Hycel S.A. (Biocode). As previously announced, the initial consideration for Biocode was €23,000,000, with €11,000,000 to be satisfied in cash, and the balance satisfied through the issue of 2,839,719 new Ordinary Shares […]